Published in J Pharmacol Exp Ther on July 01, 1982
The influence of moderate hypoalbuminaemia on the renal metabolism and dynamics of furosemide in the rabbit. Br J Pharmacol (1996) 0.82
Effect of lignocaine on arginine-vasopressin plasma levels: baseline or induced by frusemide. Br J Pharmacol (1992) 0.76
Perinatal growth restriction decreases diuretic action of furosemide in adult rats. Eur J Pharmacol (2014) 0.75
Extrahepatic metabolism of frusemide in anaesthetized rabbits. Br J Pharmacol (1995) 0.75
Response by women aged 65-79 to invitation for screening for breast cancer by mammography: a pilot study. BMJ (1990) 2.51
The Old English Medical Vocabulary: (Section of the History of Medicine). Proc R Soc Med (1940) 2.09
Simple DNA extraction method for dried blood spots and comparison of two PCR assays for diagnosis of vertical human immunodeficiency virus type 1 transmission in Rwanda. J Clin Microbiol (2004) 1.77
Characterization of regulatory functions of the varicella-zoster virus gene 63-encoded protein. J Virol (1992) 1.68
Roseobacter gallaeciensis sp. nov., a new marine bacterium isolated from rearings and collectors of the scallop Pecten maximus. Int J Syst Bacteriol (1998) 1.57
An inhibitor of the toxicity of tumour necrosis factor in the serum of patients with sarcoidosis, tuberculosis and Crohn's disease. Clin Exp Immunol (1990) 1.53
Efficacy of propafenone in preventing ventricular tachycardia: inverse correlation with rate-related prolongation of conduction time. J Am Coll Cardiol (1990) 1.40
Attenuated signature-tagged mutagenesis mutants of Brucella melitensis identified during the acute phase of infection in mice. Infect Immun (2003) 1.38
Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis Cartilage (2008) 1.30
An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin. Br J Clin Pharmacol (1988) 1.29
High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis. Clin Infect Dis (1999) 1.28
The role of oil and agalactosyl IgG in the induction of arthritis in rodent models. Eur J Immunol (1991) 1.25
Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart. Proc Natl Acad Sci U S A (1997) 1.25
Novel assay and pharmacokinetics of levamisole and p-hydroxylevamisole in human plasma and urine. Biopharm Drug Dispos (1986) 1.24
Emerging standards for diabetes care from a city-wide primary care audit. Diabet Med (1994) 1.24
Role of the mitochondrial DNA 16184-16193 poly-C tract in type 2 diabetes. Lancet (2005) 1.24
Use of laser microdissection greatly improves the recovery of DNA from sperm on microscope slides. Forensic Sci Int (2003) 1.23
Comparison of DNA sequencing and a line probe assay for detection of human immunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy. J Clin Microbiol (2001) 1.22
Serum and ascitic procalcitonin levels in cirrhotic patients with spontaneous bacterial peritonitis: diagnostic value and relationship to pro-inflammatory cytokines. Intensive Care Med (2000) 1.19
Uptake of glutamate in Corynebacterium glutamicum. 1. Kinetic properties and regulation by internal pH and potassium. Eur J Biochem (1990) 1.18
Pharmacokinetics of lidocaine after prolonged intravenous infusions in uncomplicated myocardial infarction. Ann Intern Med (1977) 1.16
Radioimmunoassay of atrial natriuretic factor: human plasma levels. Biochem Biophys Res Commun (1985) 1.13
Residual renal function in a large cohort of peritoneal dialysis patients: change over time, impact on mortality and nutrition. Perit Dial Int (2001) 1.11
Uptake of glutamate in Corynebacterium glutamicum. 2. Evidence for a primary active transport system. Eur J Biochem (1990) 1.09
Preventive dental behavior of urban mothers. J Health Hum Behav (1965) 1.07
Screening methods using sulfamethazine for determining acetylator phenotype. Clin Pharmacol Ther (1979) 1.06
Serum cytokine changes in systemic vasculitis. Immunology (1989) 1.05
Adaptations to swimming training: influence of training volume. Med Sci Sports Exerc (1991) 1.04
Tissue distribution and bioactivity of amphotericin B administered in liposomes to cancer patients. J Antimicrob Chemother (1991) 1.04
Nutraceuticals: do they represent a new era in the management of osteoarthritis? - a narrative review from the lessons taken with five products. Osteoarthritis Cartilage (2010) 1.03
Efflux of compatible solutes in Corynebacterium glutamicum mediated by osmoregulated channel activity. Eur J Biochem (1997) 1.01
Modulation of the anti-nociceptive effects of 2-arachidonoyl glycerol by peripherally administered FAAH and MGL inhibitors in a neuropathic pain model. Br J Pharmacol (2008) 1.01
Curcumin inhibits pro-inflammatory mediators and metalloproteinase-3 production by chondrocytes. Inflamm Res (2009) 1.00
Sleep and circadian phase characteristics of adolescent and young adult males in a naturalistic summertime condition. Chronobiol Int (2000) 1.00
Variability in GWAS analysis: the impact of genotype calling algorithm inconsistencies. Pharmacogenomics J (2010) 1.00
Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system. Arch Gen Psychiatry (1983) 0.99
Episodic ataxia and hemiplegia caused by the 8993T->C mitochondrial DNA mutation. J Med Genet (2007) 0.98
Longitudinal follow-up of nutritional status and its influencing factors in adults undergoing allogeneic hematopoietic cell transplantation. Bone Marrow Transplant (2012) 0.97
In-vitro activity of SCH39304 in comparison with amphotericin B and fluconazole. J Antimicrob Chemother (1990) 0.95
The role of physiotherapy after total knee arthroplasty in patients with haemophilia. Haemophilia (2008) 0.95
EfficientAgrobacterium-mediated transformation and recovery of transgenic plants from pear (Pyrus communis L.). Plant Cell Rep (1996) 0.94
First hemodialysis access selection varies with patient acuity. Adv Ren Replace Ther (2000) 0.94
Prazosin plasma concentration and blood pressure reduction. Hypertension (1982) 0.94
Antagonistic effects of thyrotropin and epidermal growth factor on thyroglobulin mRNA level in cultured thyroid cells. Eur J Biochem (1985) 0.94
A comparative study of the formation of chemically reactive drug metabolites by human liver microsomes. Br J Clin Pharmacol (1988) 0.94
The expression of G250/mn/CA9 antigen by flow cytometry: its possible implication for detection of micrometastatic renal cancer cells. Clin Cancer Res (2001) 0.94
Triggering Glutamate Excretion in Corynebacterium glutamicum by Modulating the Membrane State with Local Anesthetics and Osmotic Gradients. Appl Environ Microbiol (1995) 0.94
Antiviral efficacy and resistance in patients on antiretroviral therapy in Kigali, Rwanda: the real-life situation in 2002. HIV Med (2006) 0.93
Assessment of variability in GWAS with CRLMM genotyping algorithm on WTCCC coronary artery disease. Pharmacogenomics J (2010) 0.93
High-resolution liquid chromatographic method using ultraviolet detection for determination of ondansetron in human plasma. J Chromatogr B Biomed Sci Appl (1997) 0.92
In-vitro activity of cilofungin (LY121019) in comparison with amphotericin B. J Antimicrob Chemother (1989) 0.91
The development of monoclonal antibodies to the human mitochondrial 60-kd heat-shock protein, and their use in studying the expression of the protein in rheumatoid arthritis. Arthritis Rheum (1992) 0.91
Genotypic correlates of resistance to HIV-1 protease inhibitors on longitudinal data: the role of secondary mutations. Antivir Ther (2001) 0.91
Cardioprotective effects of ramipril and losartan in right ventricular pressure overload in the rabbit: importance of kinins and influence on angiotensin II type 1 receptor signaling pathway. Circulation (2001) 0.91
Acute and chronic role of 5-HT3 neuronal system on behavioral and neuroendocrine changes induced by intravenous cholecystokinin tetrapeptide administration in humans. Neuropsychopharmacology (1999) 0.91
Altered expression of angiogenesis and lymphangiogenesis markers in the uninvolved skin of plaque-type psoriasis. Br J Dermatol (2008) 0.91
Variant human immunodeficiency virus type 1 proteases and response to combination therapy including a protease inhibitor. Antimicrob Agents Chemother (2001) 0.90
Metabolism of procainamide and p-aminobenzoic acid in patients with chronic liver disease. Clin Pharmacol Ther (1977) 0.90
Results of a collaborative study of the EDNAP group regarding mitochondrial DNA heteroplasmy and segregation in hair shafts. Forensic Sci Int (2004) 0.90
High incidence of complications after 2-chloro-2'-deoxyadenosine combined with cyclophosphamide in patients with advanced lymphoproliferative malignancies. Ann Hematol (2004) 0.89
Effect of the duration of infusion on the disposition of lidocaine in dogs. J Pharmacol Exp Ther (1977) 0.89
[Pharmacokinetic profil of ketoprofen (author's transl)]. Ann Pharm Fr (1978) 0.88
Pulmonary disease and drug kinetics. Clin Pharmacokinet (1978) 0.88
Batch effects in the BRLMM genotype calling algorithm influence GWAS results for the Affymetrix 500K array. Pharmacogenomics J (2010) 0.88
Plasma levels of nicotine and safety of smokers wearing transdermal delivery systems during multiple simultaneous intake of nicotine and during exercise. J Clin Pharmacol (1997) 0.88
Massive diltiazem overdosage: clinical and pharmacokinetic observations. Drug Intell Clin Pharm (1986) 0.88
Evaluation of an automated immunoassay method for cytokine measurement using the Immulite Immunoassay system. Clin Chem Lab Med (1999) 0.87
Pharmacokinetics of oral diltiazem and five of its metabolites in patients with chronic renal failure. Biopharm Drug Dispos (1991) 0.86
Influence of drug formulation on drug concentration-effect relationships. Clin Pharmacokinet (1994) 0.86
Fluorescence studies of lens epithelial cells and their constituents. Photochem Photobiol (1999) 0.86
Intracranial placement of nasopharyngeal airways: is it all that rare? Emerg Med J (2006) 0.86
Melasma. G Ital Dermatol Venereol (2012) 0.86
Newer methods of labeling diagnostic agents with Tc-99m. Semin Nucl Med (2001) 0.85
Increased expression of receptor activator of NF-kappaB ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients. Clin Exp Immunol (2004) 0.85
Furosemide pharmacodynamics: effect of respiratory and acid-base disturbances. J Pharmacol Exp Ther (1986) 0.85
Interaction of hydralazine with tension development and mechanisms of calcium accumulation in K+-stimulated rabbit aortic strips. J Pharmacol Exp Ther (1978) 0.85
Effects of information about fat content on food preferences in pre-adolescent children. Appetite (1998) 0.84
Cardiovascular effects of treatment of type 2 diabetes with pioglitazone, metformin and gliclazide. Int J Clin Pract (2004) 0.84
Peptidic regulation of heart rate and interactions with the autonomic nervous system. Cardiovasc Res (1998) 0.84
Modulation of inflammation by chondroitin sulfate. Osteoarthritis Cartilage (2010) 0.84
Isopropanol and acetone potentiation of carbon tetrachloride-induced hepatotoxicity: single versus repetitive pretreatments in rats. J Toxicol Environ Health (1982) 0.83
Iron as a potential co-factor in the pathogenesis of Kaposi's sarcoma? Int J Cancer (1998) 0.83
Carotene-oxygen radical interactions. Free Radic Res Commun (1992) 0.83
Salinity effects on immune parameters of Ruditapes philippinarum challenged with Vibrio tapetis. Dis Aquat Organ (2003) 0.83
Down-regulation of the hepatic cytochrome P450 by an acute inflammatory reaction: implication of mediators in human and animal serum and in the liver. Br J Pharmacol (1997) 0.83
Selective uptake of an antibilharzial nitrothiazole compound by Schistosoma mansoni. Nature (1966) 0.83
High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM. Ann Hematol (2013) 0.82
Isolation of the putP gene of Corynebacterium glutamicum and characterization of a low-affinity uptake system for compatible solutes. Arch Microbiol (1997) 0.82
The influence of moderate hypoalbuminaemia on the renal metabolism and dynamics of furosemide in the rabbit. Br J Pharmacol (1996) 0.82
L-NAME prevents in vivo the inactivation but not the down-regulation of hepatic cytochrome P450 caused by an acute inflammatory reaction. Life Sci (2001) 0.82
A multicentre open-label safety and efficacy study of tetrodotoxin for cancer pain. Curr Oncol (2011) 0.82
Effect of atrial natriuretic peptide on bronchial tone in anesthetized rabbits. Peptides (1994) 0.82
Correlation between acetone-potentiated CCl4-induced liver injury and blood concentrations after inhalation or oral administration. Toxicol Appl Pharmacol (1986) 0.82
[Rapid diagnosis of the type of meningitis (bacterial or viral) by the assay of serum procalcitonin]. Presse Med (2000) 0.81
Pharmacokinetics of intravenous diltiazem and five of its metabolites in patients with chronic renal failure and in healthy volunteers. Biopharm Drug Dispos (1991) 0.81
Structure and function prediction of the Brucella abortus P39 protein by comparative modeling with marginal sequence similarities. Protein Eng (1999) 0.81
CD4+ and CD8+ clonal T cell expansions indicate a role of antigens in ankylosing spondylitis; a study in HLA-B27+ monozygotic twins. Clin Exp Immunol (2001) 0.81
Ex vivo pharmacodynamic study of piperacillin alone and in combination with tazobactam, compared with ticarcillin plus clavulanic acid. Antimicrob Agents Chemother (1993) 0.81